Literature DB >> 1998397

Intestinal permeability in patients with yersinia triggered reactive arthritis.

R Lahesmaa-Rantala1, K E Magnusson, K Granfors, R Leino, T Sundqvist, A Toivanen.   

Abstract

The passive intestinal permeability of patients with yersinia triggered reactive arthritis was studied using different sized polyethylene glycols (PEGs) contained in a mixture of PEG 400 and PEG 1000. The investigation was carried out at least one year after the onset of yersinia infection, and patients had neither acute gastrointestinal nor joint symptoms. The control groups included patients with uncomplicated yersiniosis as well as healthy subjects who were either HLA-B27 positive or negative. An altered intestinal barrier function to PEG molecules was detected in patients with a history of yersinia infection compared with healthy controls. No significant differences in the permeability were found between patients with or without reactive arthritis, nor was there any association of increased permeability with HLA-B27. The passive permeability of the intestinal mucosa to the larger molecules was increased for an unexpectedly long time after the acute yersinia infection, probably contributing to the perpetuation of joint symptoms in subjects susceptible to a chronic joint disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1998397      PMCID: PMC1004344          DOI: 10.1136/ard.50.2.91

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  Gastrointestinal permeability in children with cow's milk allergy: effect of milk challenge and sodium cromoglycate as assessed with polyethyleneglycols (PEG 400 and PEG 1000).

Authors:  K Fälth-Magnusson; N I Kjellman; H Odelram; T Sundqvist; K E Magnusson
Journal:  Clin Allergy       Date:  1986-11

2.  Gastrointestinal permeability in atopic and non-atopic mothers, assessed with different-sized polyethyleneglycols (PEG 400 and PEG 1000).

Authors:  K Fälth-Magnusson; N I Kjellman; T Sundqvist; K E Magnusson
Journal:  Clin Allergy       Date:  1985-11

3.  Intestinal permeability in healthy and allergic children before and after sodium-cromoglycate treatment assessed with different-sized polyethyleneglycols (PEG 400 and PEG 1000).

Authors:  K Fälth-Magnusson; N I Kjellman; K E Magnusson; T Sundqvist
Journal:  Clin Allergy       Date:  1984-05

4.  Altered intestinal permeability to low-molecular-weight polyethyleneglycols (PEG 400) in patients with Crohn's disease.

Authors:  K E Magnusson; T Sundqvist; R Sjödahl; C Tagesson
Journal:  Acta Chir Scand       Date:  1983

5.  Sequential studies in ankylosing spondylitis. Association of Klebsiella pneumoniae with active disease.

Authors:  R W Ebringer; D R Cawdell; P Cowling; A Ebringer
Journal:  Ann Rheum Dis       Date:  1978-04       Impact factor: 19.103

6.  Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis.

Authors:  K Granfors; M Viljanen; A Tiilikainen; A Toivanen
Journal:  J Infect Dis       Date:  1980-04       Impact factor: 5.226

7.  HLA-B27 related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis.

Authors:  H Mielants; E M Veys; C Cuvelier; M De Vos; L Botelberghe
Journal:  J Rheumatol       Date:  1985-04       Impact factor: 4.666

8.  Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine.

Authors:  I Bjarnason; P Williams; P Smethurst; T J Peters; A J Levi
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

9.  Acute yersinia infections in man increase intestinal permeability for low-molecular weight polyethylene glycols (PEG 400).

Authors:  R Serrander; K E Magnusson; E Kihlström; T Sundqvist
Journal:  Scand J Infect Dis       Date:  1986

10.  Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis.

Authors:  M D Smith; R A Gibson; P M Brooks
Journal:  J Rheumatol       Date:  1985-04       Impact factor: 4.666

View more
  7 in total

1.  Apically exposed, tight junction-associated beta1-integrins allow binding and YopE-mediated perturbation of epithelial barriers by wild-type Yersinia bacteria.

Authors:  F Tafazoli; A Holmström; A Forsberg; K E Magnusson
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

Review 2.  HLA-B27 and bacteria.

Authors:  J Uksila; P Toivanen
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

3.  Enhanced jejunal production of antibodies to Klebsiella and other Enterobacteria in patients with ankylosing spondylitis and rheumatoid arthritis.

Authors:  O Mäki-Ikola; R Hällgren; L Kanerud; N Feltelius; L Knutsson; K Granfors
Journal:  Ann Rheum Dis       Date:  1997-07       Impact factor: 19.103

4.  Assessment of intestinal permeability and orocecal transit time in patients with systemic sclerosis: analysis of relationships with epidemiologic and clinical parameters.

Authors:  Luigi Caserta; Laura de Magistris; Mario Secondulfo; Giancarlo Caravelli; Gabriele Riegler; Giovanna Cuomo; Salvatore D'Angelo; Caterina Naclerio; Gabriele Valentini; Romano Carratù
Journal:  Rheumatol Int       Date:  2003-02-15       Impact factor: 2.631

5.  IgA1 and IgA2 subclass antibodies against Klebsiella pneumoniae in the sera of patients with peripheral and axial types of ankylosing spondylitis.

Authors:  O Mäki-Ikola; M Nissilä; K Lehtinen; M Leirisalo-Repo; K Granfors
Journal:  Ann Rheum Dis       Date:  1995-08       Impact factor: 19.103

6.  Yersinia pseudotuberculosis disrupts intestinal barrier integrity through hematopoietic TLR-2 signaling.

Authors:  Camille Jung; Ulrich Meinzer; Nicolas Montcuquet; Elodie Thachil; Danielle Château; Raphaële Thiébaut; Maryline Roy; Ziad Alnabhani; Dominique Berrebi; Monique Dussaillant; Eric Pedruzzi; Sophie Thenet; Nadine Cerf-Bensussan; Jean-Pierre Hugot; Frederick Barreau
Journal:  J Clin Invest       Date:  2012-05-08       Impact factor: 14.808

7.  Neurotrophic Factors Protect the Intestinal Barrier from Rotavirus Insult in Mice.

Authors:  Marie Hagbom; Felipe Meira De Faria; Martin E Winberg; Sonja Westerberg; Johan Nordgren; Sumit Sharma; Åsa V Keita; Vesa Loitto; Karl-Eric Magnusson; Lennart Svensson
Journal:  mBio       Date:  2020-01-21       Impact factor: 7.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.